TRAF4 and prostate carcinoma: Additionally, TRAF4 overexpression has been implicated in prostate cancer, where it mediates K27-linked ubiquitination of the AR C-terminus, elevates intracellular cAMP levels, enhances E2F transcription factor activity, and promotes cell proliferation (38).